-
Je něco špatně v tomto záznamu ?
Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis
H. Erdem, Y. Cag, D. Ozturk-Engin, S. Defres, S. Kaya, L. Larsen, M. Poljak, B. Barsic, X. Argemi, SM. Sørensen, AL. Bohr, P. Tattevin, JD. Gunst, L. Baštáková, M. Jereb, IS. Johansen, O. Karabay, AU. Pekok, OR. Sipahi, M. Chehri, G. Beraud, G....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie
NLK
Free Medical Journals
od 1972 do Před 6 měsíci
Freely Accessible Science Journals
od 1995 do Před 6 měsíci
PubMed Central
od 1972 do Před 1 rokem
Europe PubMed Central
od 1972 do Před 6 měsíci
Open Access Digital Library
od 1972-01-01
Open Access Digital Library
od 1972-01-01
PubMed
25779579
DOI
10.1128/aac.05016-14
Knihovny.cz E-zdroje
- MeSH
- antivirové látky terapeutické užití MeSH
- dospělí MeSH
- herpetická encefalitida diagnóza farmakoterapie MeSH
- interval spolehlivosti MeSH
- lidé středního věku MeSH
- lidé MeSH
- retrospektivní studie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
Data in the literature regarding the factors that predict unfavorable outcomes in adult herpetic meningoencephalitis (HME) cases are scarce. We conducted a multicenter study in order to provide insights into the predictors of HME outcomes, with special emphasis on the use and timing of antiviral treatment. Samples from 501 patients with molecular confirmation from cerebrospinal fluid were included from 35 referral centers in 10 countries. Four hundred thirty-eight patients were found to be eligible for the analysis. Overall, 232 (52.9%) patients experienced unfavorable outcomes, 44 died, and 188 survived, with sequelae. Age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02 to 1.05), Glasgow Coma Scale score (OR, 0.84; 95% CI, 0.77 to 0.93), and symptomatic periods of 2 to 7 days (OR, 1.80; 95% CI, 1.16 to 2.79) and >7 days (OR, 3.75; 95% CI, 1.72 to 8.15) until the commencement of treatment predicted unfavorable outcomes. The outcome in HME patients is related to a combination of therapeutic and host factors. This study suggests that rapid diagnosis and early administration of antiviral treatment in HME patients are keys to a favorable outcome.
Aalborg University Hospital Department of Infectious Diseases Aalborg Denmark
Aarhus University Hospital Department of Infectious Diseases Aarhus Denmark
American University of Beirut Medical Center Beirut Lebanon
Assiut University Hospital Department of Neurology and Psychiatry Assiut Egypt
Bezmi Alem Vakif University School of Medicine Department of Neurology Istanbul Turkey
Department of Neurology Baghdad Teaching Hospital Baghdad Iraq
Haydarpaşa Numune Training and Research Hospital Department of Neurology Istanbul Turkey
Haydarpaşa Numune Training and Research Hospital Department of Radiology Istanbul Turkey
Hvidovre Hospital Department of Infectious Diseases Copenhagen Denmark
Infectious Diseases and Intensive Care Unit Pontchaillou University Hospital Rennes France
Nouvel Hôpital Civil Department of Infectious Diseases Strasbourg France
Odense University Hospital Department of Infectious Diseases Q Odense Denmark
Poitiers University Hospital Department of Infectious Diseases Poitiers France
Private Umit Hospital Department of Infectious Diseases and Clinical Microbiology Eskisehir Turkey
University Medical Centre Department of Infectious Diseases Ljubljana Slovenia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010445
- 003
- CZ-PrNML
- 005
- 20160412104845.0
- 007
- ta
- 008
- 160408s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/AAC.05016-14 $2 doi
- 024 7_
- $a 10.1128/AAC.05016-14 $2 doi
- 035 __
- $a (PubMed)25779579
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Erdem, Hakan $u GATA Haydarpasa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey hakanerdem1969@yahoo.com.
- 245 10
- $a Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis / $c H. Erdem, Y. Cag, D. Ozturk-Engin, S. Defres, S. Kaya, L. Larsen, M. Poljak, B. Barsic, X. Argemi, SM. Sørensen, AL. Bohr, P. Tattevin, JD. Gunst, L. Baštáková, M. Jereb, IS. Johansen, O. Karabay, AU. Pekok, OR. Sipahi, M. Chehri, G. Beraud, G. Shehata, RF. Del Vecchio, M. Maresca, H. Karsen, G. Sengoz, M. Sunbul, G. Yilmaz, H. Yilmaz, A. Sharif-Yakan, SS. Kanj, E. Parlak, F. Pehlivanoglu, F. Korkmaz, S. Komur, S. Kose, M. Ulug, S. Bolukcu, SA. Coskuner, N. Ince, Y. Akkoyunlu, G. Halac, E. Sahin-Horasan, H. Tireli, G. Kilicoglu, A. Al-Mahdawi, SA. Nemli, A. Inan, S. Senbayrak, JP. Stahl, H. Vahaboglu,
- 520 9_
- $a Data in the literature regarding the factors that predict unfavorable outcomes in adult herpetic meningoencephalitis (HME) cases are scarce. We conducted a multicenter study in order to provide insights into the predictors of HME outcomes, with special emphasis on the use and timing of antiviral treatment. Samples from 501 patients with molecular confirmation from cerebrospinal fluid were included from 35 referral centers in 10 countries. Four hundred thirty-eight patients were found to be eligible for the analysis. Overall, 232 (52.9%) patients experienced unfavorable outcomes, 44 died, and 188 survived, with sequelae. Age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02 to 1.05), Glasgow Coma Scale score (OR, 0.84; 95% CI, 0.77 to 0.93), and symptomatic periods of 2 to 7 days (OR, 1.80; 95% CI, 1.16 to 2.79) and >7 days (OR, 3.75; 95% CI, 1.72 to 8.15) until the commencement of treatment predicted unfavorable outcomes. The outcome in HME patients is related to a combination of therapeutic and host factors. This study suggests that rapid diagnosis and early administration of antiviral treatment in HME patients are keys to a favorable outcome.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a antivirové látky $x terapeutické užití $7 D000998
- 650 _2
- $a interval spolehlivosti $7 D016001
- 650 _2
- $a herpetická encefalitida $x diagnóza $x farmakoterapie $7 D020803
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Cag, Yasemin $u Dr. Lutfi Kirdar Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Ozturk-Engin, Derya $u Haydarpaşa Numune Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Defres, Sylviane $u Institute of Infection & Global Health, University of Liverpool, Liverpool, Merseyside, United Kingdom Tropical Infectious Diseases Unit at Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
- 700 1_
- $a Kaya, Selcuk $u Karadeniz Technical University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Trabzon, Turkey.
- 700 1_
- $a Larsen, Lykke $u Odense University Hospital, Department of Infectious Diseases Q, Odense, Denmark.
- 700 1_
- $a Poljak, Mario $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Barsic, Bruno $u Dr. Fran Mihaljevic University Hospital for Infectious Diseases, Department of Infectious Diseases, University of Zagreb School of Medicine, Zagreb, Croatia.
- 700 1_
- $a Argemi, Xavier $u Nouvel Hôpital Civil, Department of Infectious Diseases, Strasbourg, France. $7 gn_A_00008327
- 700 1_
- $a Sørensen, Signe Maj $u Aalborg University Hospital, Department of Infectious Diseases, Aalborg, Denmark.
- 700 1_
- $a Bohr, Anne Lisbeth $u Copenhagen University Hospital, Institute of Inflammation Research, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Denmark.
- 700 1_
- $a Tattevin, Pierre $u Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
- 700 1_
- $a Gunst, Jesper Damsgaard $u Aarhus University Hospital, Department of Infectious Diseases, Aarhus, Denmark.
- 700 1_
- $a Baštáková, Lenka $u Faculty Hospital Brno, Department of Infectious Diseases and Masaryk University Faculty of Medicine, Brno, Czech Republic.
- 700 1_
- $a Jereb, Matjaž $u University Medical Centre, Department of Infectious Diseases, Ljubljana, Slovenia.
- 700 1_
- $a Johansen, Isik Somuncu $u Odense University Hospital, Department of Infectious Diseases Q, Odense, Denmark.
- 700 1_
- $a Karabay, Oguz $u Sakarya University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.
- 700 1_
- $a Pekok, Abdullah Umut $u Private Erzurum Sifa Hospital, Department of Infectious Diseases and Clinical Microbiology, Erzurum, Turkey.
- 700 1_
- $a Sipahi, Oguz Resat $u Ege University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.
- 700 1_
- $a Chehri, Mahtab $u Hvidovre Hospital, Department of Infectious Diseases, Copenhagen, Denmark.
- 700 1_
- $a Beraud, Guillaume $u Poitiers University Hospital, Department of Infectious Diseases, Poitiers, France.
- 700 1_
- $a Shehata, Ghaydaa $u Assiut University Hospital, Department of Neurology and Psychiatry, Assiut, Egypt.
- 700 1_
- $a Del Vecchio, Rosa Fontana $u University of Catania, Section of Infectious Diseases, Department of Clinical and Molecular Biomedicine, Catania, Italy.
- 700 1_
- $a Maresca, Mauro $u University of Catania, Section of Infectious Diseases, Department of Clinical and Molecular Biomedicine, Catania, Italy.
- 700 1_
- $a Karsen, Hasan $u Harran University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sanliurfa, Turkey.
- 700 1_
- $a Sengoz, Gonul $u Haseki Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Sunbul, Mustafa $u Ondokuz Mayis University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Samsun, Turkey.
- 700 1_
- $a Yilmaz, Gulden $u Ankara University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey.
- 700 1_
- $a Yilmaz, Hava $u Ondokuz Mayis University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Samsun, Turkey.
- 700 1_
- $a Sharif-Yakan, Ahmad $u American University of Beirut Medical Center, Beirut, Lebanon.
- 700 1_
- $a Kanj, Souha Shararah $u American University of Beirut Medical Center, Beirut, Lebanon.
- 700 1_
- $a Parlak, Emine $u Ataturk University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzurum, Turkey.
- 700 1_
- $a Pehlivanoglu, Filiz $u Haseki Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Korkmaz, Fatime $u Konya Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Konya, Turkey.
- 700 1_
- $a Komur, Suheyla $u Cukurova University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Adana, Turkey.
- 700 1_
- $a Kose, Sukran $u Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.
- 700 1_
- $a Ulug, Mehmet $u Private Umit Hospital, Department of Infectious Diseases and Clinical Microbiology, Eskisehir, Turkey.
- 700 1_
- $a Bolukcu, Sibel $u Haydarpaşa Numune Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Coskuner, Seher Ayten $u İzmir Bozyaka Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.
- 700 1_
- $a Ince, Nevin $u Düzce University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Konuralp, Düzce, Turkey.
- 700 1_
- $a Akkoyunlu, Yasemin $u Bezmi Alem Vakif University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey. $7 gn_A_00003002
- 700 1_
- $a Halac, Gulistan $u Bezmi Alem Vakif University, School of Medicine, Department of Neurology, Istanbul, Turkey.
- 700 1_
- $a Sahin-Horasan, Elif $u Mersin University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Mersin, Turkey.
- 700 1_
- $a Tireli, Hulya $u Haydarpaşa Numune Training and Research Hospital, Department of Neurology, Istanbul, Turkey.
- 700 1_
- $a Kilicoglu, Gamze $u Haydarpaşa Numune Training and Research Hospital, Department of Radiology, Istanbul, Turkey.
- 700 1_
- $a Al-Mahdawi, Akram $u Department of Neurology, Baghdad Teaching Hospital, Baghdad, Iraq. $7 gn_A_00004570
- 700 1_
- $a Nemli, Salih Atakan $u Katip Celebi University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.
- 700 1_
- $a Inan, Asuman $u Haydarpaşa Numune Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Senbayrak, Seniha $u Haydarpaşa Numune Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 700 1_
- $a Stahl, Jean Paul $u Joseph Fourier University and University Hospital of Grenoble, Department of Infectious Diseases, Grenoble, France.
- 700 1_
- $a Vahaboglu, Haluk $u Medeniyet University, Goztepe Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
- 773 0_
- $w MED00009215 $t Antimicrobial agents and chemotherapy $x 1098-6596 $g Roč. 59, č. 6 (2015), s. 3084-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25779579 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160412104928 $b ABA008
- 999 __
- $a ok $b bmc $g 1113874 $s 934813
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 59 $c 6 $d 3084-9 $e 20150316 $i 1098-6596 $m Antimicrobial agents and chemotherapy $n Antimicrob Agents Chemother $x MED00009215
- LZP __
- $a Pubmed-20160408
